Drug evaluation by biopharmaceutics classification system

被引：0
|
作者：
Baek, MS [1 ]
Choi, SO [1 ]
Park, KS [1 ]
Jung, SH [1 ]
Yoon, KE [1 ]
Chung, SY [1 ]
机构：
[1] Korea Food & Drug Adm, Natl Inst Toxicol Res, Div Bioequivalence, Seoul 122704, South Korea
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
432
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [31] Polymorphic and Quantum Chemistry Characterization of Candesartan Cilexetil: Importance for the Correct Drug Classification According to Biopharmaceutics Classification System
    Débora Priscila de Campos
    Neila Márcia Silva-Barcellos
    Renata Rodrigues Lima
    Ranylson Marcello Leal Savedra
    Melissa Fabíola Siqueira
    Maria Irene Yoshida
    Wagner da Nova Mussel
    Jacqueline de Souza
    AAPS PharmSciTech, 2018, 19 : 3019 - 3028
  • [32] Biopharmaceutics Classification System-Based Biowaivers for Generic Oncology Drug Products: Case Studies
    Tampal, Nilufer
    Mandula, Haritha
    Zhang, Hongling
    Li, Bing V.
    Nguyen, Hoainhon
    Conner, Dale P.
    AAPS PHARMSCITECH, 2015, 16 (01): : 5 - 9
  • [33] Predicting Interactions between Rifampin and Antihypertensive Drugs Using the Biopharmaceutics Drug Disposition Classification System
    Liu, Wei
    Yan, Tingting
    Chen, Ken
    Yang, Li
    Benet, Leslie Z.
    Zhai, Suodi
    PHARMACOTHERAPY, 2020, 40 (04): : 274 - 290
  • [34] Biopharmaceutics Classification System-Based Biowaivers for Generic Oncology Drug Products: Case Studies
    Nilufer Tampal
    Haritha Mandula
    Hongling Zhang
    Bing V. Li
    Hoainhon Nguyen
    Dale P. Conner
    AAPS PharmSciTech, 2015, 16 : 5 - 9
  • [35] Effects of Uremic Toxins on Transport and Metabolism of Different Biopharmaceutics Drug Disposition Classification System Xenobiotics
    Reyes, Maribel
    Benet, Leslie Z.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (09) : 3831 - 3842
  • [36] Drug solubility in biorelevant media in the context of an inhalation-based biopharmaceutics classification system (iBCS)
    Floroiu, Andreea
    Loretz, Brigitta
    Kraemer, Johannes
    Lehr, Claus-Michael
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 197
  • [37] Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
    Lawrence X. Yu
    Gordon L. Amidon
    James E. Polli
    Hong Zhao
    Mehul U. Mehta
    Dale P. Conner
    Vinod P. Shah
    Lawrence J. Lesko
    Mei-Ling Chen
    Vincent H. L. Lee
    Ajaz S. Hussain
    Pharmaceutical Research, 2002, 19 : 921 - 925
  • [38] The fundamental variables of the biopharmaceutics classification system (BCS): a commentary
    van de Waterbeemd, H
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 7 (01) : 1 - 3
  • [39] The biopharmaceutics classification system (BCS) differences matter in be determination?
    Amidon, Gordon L.
    Walgreen, Charles R., Jr.
    DRUG METABOLISM REVIEWS, 2006, 38 : 29 - 29
  • [40] Drug evaluation by biopharmaceutical classification system
    Baek, MS
    Choi, SO
    Park, KS
    Jung, SH
    Yoon, KE
    Chung, SY
    DRUG METABOLISM REVIEWS, 2003, 35 : 149 - 149
12345